Back
ProQR Therapeutics NV Vs. argenx SE Industry Stock Comparison
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.63
Seasonality Move:
8.38%
Buy
64
ARGX
argenx SE
Last Price:
606.26
Seasonality Move:
44.25%
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.62. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
argenx SE (ARGX)
is a Buy
Is argenx SE a Buy, Sell or Hold?
- The current argenx SE [ARGX] share price is $605.92. The Score for ARGX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ARGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.62
The current trend is moderately bullish and PRQR is experiencing slight selling pressure.
ARGX Stock Price Chart
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | -35463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.49 - 3.87) | Sell |
| Bollinger Bands (100): | (1.55 - 3.21) | Buy |
ARGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.14 | Buy |
| Relative Strength Index (14 RSI): | 62.35 | Buy |
| Chaikin Money Flow: | 4775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (561.05 - 597.33) | Buy |
| Bollinger Bands (100): | (489.16 - 569.9) | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.74 | Sell |
| 20-day SMA: | 3.68 | Sell |
| 50-day SMA: | 2.84 | Buy |
| 200-day SMA: | 2.19 | Buy |
| 8-day EMA: | 3.69 | Sell |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.08 | Buy |
| 200-day EMA: | 2.33 | Buy |
ARGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 586.92 | Buy |
| 20-day SMA: | 584.24 | Buy |
| 50-day SMA: | 557.51 | Buy |
| 200-day SMA: | 458.05 | Buy |
| 8-day EMA: | 590.3 | Buy |
| 20-day EMA: | 581.88 | Buy |
| 50-day EMA: | 560.51 | Buy |
| 200-day EMA: | 489.68 | Buy |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
argenx SE Earnings Growth & ARGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.81 per share, and an increase next year of $6.89 per share.
ProQR Therapeutics NV Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
argenx SE Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||